{
  "index": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49,
    50,
    51,
    52,
    53,
    54,
    55,
    56,
    57,
    58,
    59,
    60,
    61,
    62,
    63,
    64,
    65,
    66,
    67,
    68,
    69,
    70,
    71,
    72,
    73,
    74,
    75,
    76,
    77,
    78,
    79,
    80,
    81,
    82,
    83,
    84,
    85,
    86,
    87,
    88,
    89,
    90,
    91,
    92,
    93,
    94,
    95,
    96,
    97,
    98,
    99,
    100,
    101,
    102,
    103,
    104,
    105,
    106,
    107,
    108,
    109,
    110,
    111,
    112,
    113,
    114,
    115,
    116,
    117,
    118,
    119,
    120,
    121,
    122,
    123,
    124,
    125,
    126,
    127,
    128,
    129,
    130,
    131,
    132,
    133,
    134,
    135,
    136,
    137,
    138,
    139,
    140,
    141,
    142,
    143,
    144,
    145,
    146,
    147,
    148,
    149,
    150,
    151,
    152,
    153,
    154,
    155,
    156,
    157,
    158,
    159,
    160,
    161,
    162
  ],
  "columns": [
    "seq_num",
    "section",
    "diff_type",
    "base_text",
    "compare_text",
    "confidence_score"
  ],
  "data": [
    [1, "Table of Contents", 0, "VERSION HISTORY", "VERSION HISTORY", 1.0],
    [2, "Table of Contents", 0, "TABLE OF CONTENTS", "TABLE OF CONTENTS", 1.0],
    [3, "Table of Contents", 0, "Introduction", "Introduction", 1.0],
    [
      4,
      "Table of Contents",
      0,
      "Background and rationale for conducting this study",
      "Background and rationale for conducting this study",
      1.0
    ],
    [5, "Table of Contents", 0, "Background", "Background", 1.0],
    [
      6,
      "Table of Contents",
      0,
      "Rationale for conducting this study",
      "Rationale for conducting this study",
      1.0
    ],
    [
      7,
      "Table of Contents",
      0,
      "Rationale for study design, doses and control groups",
      "Rationale for study design, doses and control groups",
      1.0
    ],
    [
      8,
      "Table of Contents",
      0,
      "Benefit/risk and ethical assessment",
      "Benefit/risk and ethical assessment",
      1.0
    ],
    [9, "Table of Contents", 0, "Study Design", "Study Design", 1.0],
    [10, "Table of Contents", 0, "Study Objectives", "Study Objectives", 1.0],
    [11, "Table of Contents", 0, "Primary Objective", "Primary Objective", 1.0],
    [
      12,
      "Table of Contents",
      0,
      "Secondary Objectives",
      "Secondary Objectives",
      1.0
    ],
    [13, "Table of Contents", 0, "Safety Objective", "Safety Objective", 1.0],
    [
      14,
      "Table of Contents",
      0,
      "Patient selection, enrolment, randomisation, restrictions, discontinuation and withdrawal",
      "Patient selection, enrolment, randomisation, restrictions, discontinuation and withdrawal",
      1.0
    ],
    [
      15,
      "Table of Contents",
      0,
      "Inclusion criteria",
      "Inclusion criteria",
      1.0
    ],
    [
      16,
      "Table of Contents",
      0,
      "Exclusion criteria",
      "Exclusion criteria",
      1.0
    ],
    [
      17,
      "Table of Contents",
      0,
      "Patient enrolment and randomization",
      "Patient enrolment and randomization",
      1.0
    ],
    [
      18,
      "Table of Contents",
      0,
      "Procedures for handling incorrectly enrolled or randomised patients",
      "Procedures for handling incorrectly enrolled or randomised patients",
      1.0
    ],
    [
      19,
      "Table of Contents",
      0,
      "Methods for assigning treatment groups",
      "Methods for assigning treatment groups",
      1.0
    ],
    [
      20,
      "Table of Contents",
      0,
      "Methods for ensuring blinding",
      "Methods for ensuring blinding",
      1.0
    ],
    [
      21,
      "Table of Contents",
      0,
      "Methods for unblinding",
      "Methods for unblinding",
      1.0
    ],
    [22, "Table of Contents", 0, "Restrictions", "Restrictions", 1.0],
    [
      23,
      "Table of Contents",
      0,
      "Asthma medication restrictions",
      "Asthma medication restrictions",
      1.0
    ],
    [
      24,
      "Table of Contents",
      0,
      "Other medication restrictions",
      "Other medication restrictions",
      1.0
    ],
    [
      25,
      "Table of Contents",
      0,
      "Other restrictions",
      "Other restrictions",
      1.0
    ],
    [
      26,
      "Table of Contents",
      0,
      "Discontinuation of investigational product",
      "Discontinuation of investigational product",
      1.0
    ],
    [
      27,
      "Table of Contents",
      0,
      "Procedures for discontinuation of a patient from investigational product",
      "Procedures for discontinuation of a patient from investigational product",
      1.0
    ],
    [
      28,
      "Table of Contents",
      0,
      "Criteria for withdrawal",
      "Criteria for withdrawal",
      1.0
    ],
    [29, "Table of Contents", 0, "Screen failures", "Screen failures", 1.0],
    [
      30,
      "Table of Contents",
      0,
      "Withdrawal due to recruitment completion in a randomization stratum",
      "Withdrawal due to recruitment completion in a randomization stratum",
      1.0
    ],
    [
      31,
      "Table of Contents",
      0,
      "Withdrawal of the informed consent/assent",
      "Withdrawal of the informed consent/assent",
      1.0
    ],
    [
      32,
      "Table of Contents",
      0,
      "Withdrawal of informed consent/assent for donated biological samples",
      "Withdrawal of informed consent/assent for donated biological samples",
      1.0
    ],
    [
      33,
      "Table of Contents",
      0,
      "Discontinuation of the study",
      "Discontinuation of the study",
      1.0
    ],
    [
      34,
      "Table of Contents",
      0,
      "Study plan and timing of procedures",
      "Study plan and timing of procedures",
      1.0
    ],
    [
      35,
      "Table of Contents",
      0,
      "Asthma control questionnaire (ACQ-6)",
      "Asthma control questionnaire (ACQ-6)",
      1.0
    ],
    [
      36,
      "Table of Contents",
      0,
      "St. George's Respiratory Questionnaire  (SGRQ)",
      "St. George's Respiratory Questionnaire  (SGRQ)",
      1.0
    ],
    [
      37,
      "Table of Contents",
      0,
      "Proportion of patients with \u22651 asthma exacerbation during 48 weeks of treatment",
      "Proportion of patients with \u22651 asthma exacerbation during 48 weeks of treatment",
      1.0
    ],
    [
      38,
      "Table of Contents",
      0,
      "Time to first exacerbation",
      "Time to first exacerbation",
      1.0
    ],
    [
      39,
      "Table of Contents",
      0,
      "Forced expiratory volume in 1 second",
      "Forced expiratory volume in 1 second",
      1.0
    ],
    [
      40,
      "Table of Contents",
      0,
      "Annual rate of asthma exacerbations that are associated with an emergency room/urgent care visit or a hospitalization",
      "Annual rate of asthma exacerbations that are associated with an emergency room/urgent care visit or a hospitalization",
      1.0
    ],
    [
      41,
      "Table of Contents",
      0,
      "Calculation or derivation of safety variable(s)",
      "Calculation or derivation of safety variable(s)",
      1.0
    ],
    [42, "Table of Contents", 0, "Safety variables", "Safety variables", 1.0],
    [
      43,
      "Table of Contents",
      0,
      "Calculation or derivation of patient reported outcome variables",
      "Calculation or derivation of patient reported outcome variables",
      1.0
    ],
    [
      44,
      "Table of Contents",
      0,
      "Asthma Symptom Score",
      "Asthma Symptom Score",
      1.0
    ],
    [
      45,
      "Table of Contents",
      0,
      "Electronic diary variables",
      "Electronic diary variables",
      1.0
    ],
    [
      46,
      "Table of Contents",
      0,
      "Calculation or derivation of pharmacokinetic variables",
      "Calculation or derivation of pharmacokinetic variables",
      1.0
    ],
    [
      47,
      "Table of Contents",
      0,
      "Calculation or derivation of immunogenicity variables",
      "Calculation or derivation of immunogenicity variables",
      1.0
    ],
    [
      48,
      "Table of Contents",
      0,
      "Methods for statistical analyses",
      "Methods for statistical analyses",
      1.0
    ],
    [
      49,
      "Table of Contents",
      0,
      "Analysis of the primary variable (s)",
      "Analysis of the primary variable (s)",
      1.0
    ],
    [
      50,
      "Table of Contents",
      0,
      "Analysis of the secondary variable(s)",
      "Analysis of the secondary variable(s)",
      1.0
    ],
    [
      51,
      "Table of Contents",
      0,
      "Analysis methods for secondary efficacy variables",
      "Analysis methods for secondary efficacy variables",
      1.0
    ],
    [
      52,
      "Table of Contents",
      0,
      "Analysis methods for safety variables",
      "Analysis methods for safety variables",
      1.0
    ],
    [
      53,
      "Table of Contents",
      0,
      "Analysis methods for pharmacokinetic variables",
      "Analysis methods for pharmacokinetic variables",
      1.0
    ],
    [
      54,
      "Table of Contents",
      0,
      "Analysis method for immunogenicity variables",
      "Analysis method for immunogenicity variables",
      1.0
    ],
    [55, "Table of Contents", 0, "Subgroup analysis", "Subgroup analysis", 1.0],
    [
      56,
      "Table of Contents",
      0,
      "Sensitivity analysis",
      "Sensitivity analysis",
      1.0
    ],
    [57, "Table of Contents", 0, "Interim analysis", "Interim analysis", 1.0],
    [
      58,
      "Table of Contents",
      0,
      "Study and data management by Astrazeneca",
      "Study and data management by Astrazeneca",
      1.0
    ],
    [
      59,
      "Table of Contents",
      0,
      "Training of study site personnel",
      "Training of study site personnel",
      1.0
    ],
    [
      60,
      "Table of Contents",
      0,
      "Monitoring of the study",
      "Monitoring of the study",
      1.0
    ],
    [61, "Table of Contents", 0, "Source data", "Source data", 1.0],
    [62, "Table of Contents", 0, "Recording of data", "Recording of data", 1.0],
    [63, "Table of Contents", 0, "Study agreements", "Study agreements", 1.0],
    [
      64,
      "Table of Contents",
      0,
      "Archiving of study documents",
      "Archiving of study documents",
      1.0
    ],
    [
      65,
      "Table of Contents",
      0,
      "Study timetable and end of study",
      "Study timetable and end of study",
      1.0
    ],
    [
      66,
      "Table of Contents",
      0,
      "Data management by AstraZeneca",
      "Data management by AstraZeneca",
      1.0
    ],
    [
      67,
      "Table of Contents",
      0,
      "Ethical and regulatory requirements",
      "Ethical and regulatory requirements",
      1.0
    ],
    [
      68,
      "Table of Contents",
      0,
      "Ethical conduct of the study",
      "Ethical conduct of the study",
      1.0
    ],
    [
      69,
      "Table of Contents",
      0,
      "Patient data protection",
      "Patient data protection",
      1.0
    ],
    [
      70,
      "Table of Contents",
      0,
      "Ethics and regulatory review",
      "Ethics and regulatory review",
      1.0
    ],
    [
      71,
      "Table of Contents",
      0,
      "Informed consent/assent",
      "Informed consent/assent",
      1.0
    ],
    [
      72,
      "Table of Contents",
      0,
      "Changes to the protocol and informed consent form/assent form",
      "Changes to the protocol and informed consent form/assent form",
      1.0
    ],
    [
      73,
      "Table of Contents",
      0,
      "Audits and inspections",
      "Audits and inspections",
      1.0
    ],
    [
      74,
      "Table of Contents",
      0,
      "List of References",
      "List of References",
      1.0
    ],
    [75, "Table of Contents", 0, "PROTOCOL SYNOPSIS", "PROTOCOL SYNOPSIS", 1.0],
    [
      76,
      "Table of Contents",
      0,
      "Figure 1 Study flow chart",
      "Figure 1 Study flow chart",
      1.0
    ],
    [
      77,
      "Table of Contents",
      0,
      "Table 1 Study Plan - Screening period",
      "Table 1 Study Plan - Screening period",
      1.0
    ],
    [
      78,
      "Table of Contents",
      0,
      "Table 2 Study Plan - Randomization, treatment period, and follow-up",
      "Table 2 Study Plan - Randomization, treatment period, and follow-up",
      1.0
    ],
    [79, "Table of Contents", 0, "Screening period", "Screening period", 1.0],
    [
      80,
      "Table of Contents",
      0,
      "Enrolment (Visit 1)",
      "Enrolment (Visit 1)",
      1.0
    ],
    [
      81,
      "Table of Contents",
      0,
      "Run-in (Visit 2, Visit 3)",
      "Run-in (Visit 2, Visit 3)",
      1.0
    ],
    [82, "Table of Contents", 0, "Re-screening", "Re-screening", 1.0],
    [
      83,
      "Table of Contents",
      0,
      "Procedures for Patients Who Experience an Exacerbation during Screening",
      "Procedures for Patients Who Experience an Exacerbation during Screening",
      1.0
    ],
    [84, "Table of Contents", 0, "Treatment period", "Treatment period", 1.0],
    [85, "Table of Contents", 0, "Follow-up period", "Follow-up period", 1.0],
    [
      86,
      "Table of Contents",
      0,
      "STUDY ASSESSMENTS AND PROCEDURES",
      "STUDY ASSESSMENTS AND PROCEDURES",
      1.0
    ],
    [
      87,
      "Table of Contents",
      0,
      "Efficacy assessments",
      "Efficacy assessments",
      1.0
    ],
    [
      88,
      "Table of Contents",
      0,
      "Assessment of asthma exacerbations",
      "Assessment of asthma exacerbations",
      1.0
    ],
    [89, "Table of Contents", 0, "Spirometry", "Spirometry", 1.0],
    [
      90,
      "Table of Contents",
      0,
      "Reversibility test",
      "Reversibility test",
      1.0
    ],
    [
      91,
      "Table of Contents",
      0,
      "Figure 2 Reversibility testing algorithm",
      "Figure 2 Reversibility testing algorithm",
      1.0
    ],
    [
      92,
      "Table of Contents",
      0,
      "Home peak expiratory flow testing",
      "Home peak expiratory flow testing",
      1.0
    ],
    [
      93,
      "Table of Contents",
      0,
      "Safety assessments",
      "Safety assessments",
      1.0
    ],
    [
      94,
      "Table of Contents",
      0,
      "Physical examination",
      "Physical examination",
      1.0
    ],
    [
      95,
      "Table of Contents",
      0,
      "Complete physical examination",
      "Complete physical examination",
      1.0
    ],
    [
      96,
      "Table of Contents",
      0,
      "Brief physical examination",
      "Brief physical examination",
      1.0
    ],
    [97, "Table of Contents", 0, "Vital signs", "Vital signs", 1.0],
    [98, "Table of Contents", 0, "ECG", "ECG", 1.0],
    [
      99,
      "Table of Contents",
      0,
      "Safety laboratory tests",
      "Safety laboratory tests",
      1.0
    ],
    [
      100,
      "Table of Contents",
      0,
      "Table 3 List of safety laboratory tests",
      "Table 3 List of safety laboratory tests",
      1.0
    ],
    [101, "Table of Contents", 0, "Pregnancy Test", "Pregnancy Test", 1.0],
    [
      102,
      "Table of Contents",
      0,
      "Other assessments and procedures",
      "Other assessments and procedures",
      1.0
    ],
    [
      103,
      "Table of Contents",
      0,
      "Weight and height",
      "Weight and height",
      1.0
    ],
    [
      104,
      "Table of Contents",
      0,
      "Patient reported outcomes",
      "Patient reported outcomes",
      1.0
    ],
    [
      105,
      "Table of Contents",
      0,
      "Asthma daily diary",
      "Asthma daily diary",
      1.0
    ],
    [
      106,
      "Table of Contents",
      0,
      "Asthma control questionnaire (ACQ-6)",
      "Asthma control questionnaire (ACQ-6)",
      1.0
    ],
    [
      107,
      "Table of Contents",
      0,
      "St. George's Respiratory Questionnaire (SGRQ)",
      "St. George's Respiratory Questionnaire (SGRQ)",
      1.0
    ],
    [
      108,
      "Table of Contents",
      0,
      "Healthcare resource utilization",
      "Healthcare resource utilization",
      1.0
    ],
    [
      109,
      "Table of Contents",
      0,
      "Other run-in assessments",
      "Other run-in assessments",
      1.0
    ],
    [110, "Table of Contents", 0, "Serology", "Serology", 1.0],
    [111, "Table of Contents", 0, "Pharmacokinetics", "Pharmacokinetics", 1.0],
    [112, "Table of Contents", 0, "Immunogenicity", "Immunogenicity", 1.0],
    [
      113,
      "Table of Contents",
      0,
      "Handling of biological samples",
      "Handling of biological samples",
      1.0
    ],
    [
      114,
      "Table of Contents",
      0,
      "Labelling and shipment of biological samples",
      "Labelling and shipment of biological samples",
      1.0
    ],
    [
      115,
      "Table of Contents",
      0,
      "Chain of custody of biological samples",
      "Chain of custody of biological samples",
      1.0
    ],
    [
      116,
      "Table of Contents",
      0,
      "SAFETY REPORTING AND MEDICAL MANAGEMENT",
      "SAFETY REPORTING AND MEDICAL MANAGEMENT",
      1.0
    ],
    [
      117,
      "Table of Contents",
      0,
      "Definition of adverse events",
      "Definition of adverse events",
      1.0
    ],
    [
      118,
      "Table of Contents",
      0,
      "Definitions of serious adverse event",
      "Definitions of serious adverse event",
      1.0
    ],
    [
      119,
      "Table of Contents",
      0,
      "Recording of adverse events",
      "Recording of adverse events",
      1.0
    ],
    [
      120,
      "Table of Contents",
      0,
      "Time period for collection of adverse events",
      "Time period for collection of adverse events",
      1.0
    ],
    [
      121,
      "Table of Contents",
      0,
      "Follow-up of unresolved adverse events",
      "Follow-up of unresolved adverse events",
      1.0
    ],
    [122, "Table of Contents", 0, "Variables", "Variables", 1.0],
    [
      123,
      "Table of Contents",
      0,
      "Causality collection",
      "Causality collection",
      1.0
    ],
    [
      124,
      "Table of Contents",
      0,
      "Adverse events based on signs and symptoms",
      "Adverse events based on signs and symptoms",
      1.0
    ],
    [
      125,
      "Table of Contents",
      0,
      "Adverse events based on examinations and tests",
      "Adverse events based on examinations and tests",
      1.0
    ],
    [126, "Table of Contents", 0, "Hy's Law", "Hy's Law", 1.0],
    [
      127,
      "Table of Contents",
      0,
      "Symptoms of the disease under study",
      "Symptoms of the disease under study",
      1.0
    ],
    [
      128,
      "Table of Contents",
      0,
      "Reporting of serious adverse events",
      "Reporting of serious adverse events",
      1.0
    ],
    [129, "Table of Contents", 0, "Overdose", "Overdose", 1.0],
    [130, "Table of Contents", 0, "Pregnancy", "Pregnancy", 1.0],
    [
      131,
      "Table of Contents",
      0,
      "Maternal exposure",
      "Maternal exposure",
      1.0
    ],
    [
      132,
      "Table of Contents",
      0,
      "Paternal exposure",
      "Paternal exposure",
      1.0
    ],
    [
      133,
      "Table of Contents",
      0,
      "INVESTIGATIONAL PRODUCT AND OTHER TREATMENTS",
      "INVESTIGATIONAL PRODUCT AND OTHER TREATMENTS",
      1.0
    ],
    [
      134,
      "Table of Contents",
      0,
      "Identity of investigational product(s)",
      "Identity of investigational product(s)",
      1.0
    ],
    [
      135,
      "Table of Contents",
      0,
      "Table 4 Identity of investigational product",
      "Table 4 Identity of investigational product",
      1.0
    ],
    [136, "Table of Contents", 0, "Labelling", "Labelling", 1.0],
    [137, "Table of Contents", 0, "Storage", "Storage", 1.0],
    [
      138,
      "Table of Contents",
      0,
      "IP administration and treatment Compliance",
      "IP administration and treatment Compliance",
      1.0
    ],
    [
      139,
      "Table of Contents",
      0,
      "Figure 3 Injection sites and rotation scheme",
      "Figure 3 Injection sites and rotation scheme",
      1.0
    ],
    [140, "Table of Contents", 0, "Accountability", "Accountability", 1.0],
    [
      141,
      "Table of Contents",
      0,
      "Concomitant and other treatments",
      "Concomitant and other treatments",
      1.0
    ],
    [
      142,
      "Table of Contents",
      0,
      "Concomitant medication",
      "Concomitant medication",
      1.0
    ],
    [
      143,
      "Table of Contents",
      0,
      "Background medication",
      "Background medication",
      1.0
    ],
    [
      144,
      "Table of Contents",
      0,
      "Rescue medication",
      "Rescue medication",
      1.0
    ],
    [
      145,
      "Table of Contents",
      0,
      "Other concomitant treatment",
      "Other concomitant treatment",
      1.0
    ],
    [
      146,
      "Table of Contents",
      0,
      "Management of investigational product-related reactions",
      "Management of investigational product-related reactions",
      1.0
    ],
    [
      147,
      "Table of Contents",
      0,
      "STATISTICAL ANALYSES BY ASTRAZENECA",
      "STATISTICAL ANALYSES BY ASTRAZENECA",
      1.0
    ],
    [
      148,
      "Table of Contents",
      0,
      "Statistical considerations",
      "Statistical considerations",
      1.0
    ],
    [
      149,
      "Table of Contents",
      0,
      "Sample size estimate",
      "Sample size estimate",
      1.0
    ],
    [
      150,
      "Table of Contents",
      0,
      "Definitions of analysis sets",
      "Definitions of analysis sets",
      1.0
    ],
    [
      151,
      "Table of Contents",
      0,
      "All patients analysis set",
      "All patients analysis set",
      1.0
    ],
    [
      152,
      "Table of Contents",
      0,
      "Full analysis set",
      "Full analysis set",
      1.0
    ],
    [
      153,
      "Table of Contents",
      0,
      "Safety analysis set",
      "Safety analysis set",
      1.0
    ],
    [
      154,
      "Table of Contents",
      0,
      "Pharmacokinetic analysis set",
      "Pharmacokinetic analysis set",
      1.0
    ],
    [
      155,
      "Table of Contents",
      0,
      "Variables for analyses",
      "Variables for analyses",
      1.0
    ],
    [
      156,
      "Table of Contents",
      0,
      "Calculation or derivation of efficacy variables",
      "Calculation or derivation of efficacy variables",
      1.0
    ],
    [
      157,
      "Table of Contents",
      0,
      "Exacerbation rate",
      "Exacerbation rate",
      1.0
    ],
    [
      158,
      "Table of Contents",
      0,
      "Appendix A Additional Safety Information",
      "Appendix A Additional Safety Information",
      1.0
    ],
    [
      159,
      "Table of Contents",
      0,
      "Appendix D Anaphylaxis: definition, signs, symptoms and management",
      "Appendix D Anaphylaxis: definition, signs, symptoms and management",
      1.0
    ],
    [
      160,
      "Table of Contents",
      0,
      "Appendix E Background Therapy Equivalence Table",
      "Appendix E Background Therapy Equivalence Table",
      1.0
    ],
    [
      161,
      "Table of Contents",
      0,
      "Appendix F Restricted and prohibited medications",
      "Appendix F Restricted and prohibited medications",
      1.0
    ],
    [
      162,
      "Table of Contents",
      0,
      "Table 5 Asthma medication restrictions",
      "Table 5 Asthma medication restrictions",
      1.0
    ],
    [
      163,
      "Table of Contents",
      0,
      "Table 6 Other medication restrictions",
      "Table 6 Other medication restrictions",
      1.0
    ]
  ]
}
